Nippon India Active Momentum Fund
Direct Plan · IDCW Option · Nippon India Mutual Fund
Returns
Annualised (CAGR) returns for periods over a year.
Want to invest in this fund?
Open a free demat & trading account with Zerodha to invest in direct mutual funds with zero commission.
Rank in Category
| Period | This Fund | Category Avg. | Rank |
|---|---|---|---|
| 1W | +4.37% | +3.52% | 79 of 255 |
| 1M | +3.01% | +1.97% | 81 of 255 |
| 3M | -4.52% | -3.45% | 156 of 252 |
| 6M | +5.17% | +2.92% | 77 of 251 |
| YTD | +4.19% | +1.21% | 80 of 255 |
| 1Y | +5.83% | +1.11% | 57 of 232 |
| INCEPTION | +15.61% | — | — |
Ranked among: Equity Scheme - Sectoral/ Thematic.
Rolling Returns
| Period | Average | Best | Worst | Positive Periods | Consistency |
|---|---|---|---|---|---|
| 3M | +3.51% | +18.34% | -10.47% | 74% | 30% |
| 6M | +5.89% | +20.71% | -8.26% | 89% | 37% |
| 1Y | +9.83% | +19.14% | -0.77% | 99% | 43% |
Rolling returns show the average, best and worst outcome an investor would have seen entering at any point in the window.
NAV History
AUM Trend (₹ Cr, quarterly average)
Expense Ratio Trend
Portfolio · Sep 2026
Asset Allocation
- Equity98.57%
- Debt0.00%
- Cash1.43%
- Other0.00%
Market Cap Split
- Large Cap41.90%
- Mid Cap28.87%
- Small Cap27.80%
- Others1.43%
Fundamentals
| Fund | Category | |
|---|---|---|
| P/E | 33.11 | 28.09 |
| P/B | 4.54 | 4.63 |
| Price / Sales | 4.30 | 3.31 |
| Price / Cash Flow | 29.66 | 21.08 |
| Dividend Yield (%) | 0.54 | 1.16 |
Holdings · Sep 2026
| Holding | Sector | Weight | Change (1M) |
|---|---|---|---|
| HDFC Bank | Banks | 6.30% | +0.72% |
| ICICI Bank | Banks | 6.10% | -0.93% |
| Kotak Bank | Banks | 4.25% | — |
| Dixon Technologies | Consumer Durables | 3.78% | +1.29% |
| Sun Pharmaceutical | Pharmaceuticals & Biotechnology | 3.44% | +0.64% |
| Bajaj Finance | Finance | 3.23% | -0.50% |
| TVS Motors | Automobiles | 3.20% | +0.79% |
| Affle 3i | IT - Services | 3.12% | +0.80% |
| Torrent Pharmaceuticals | Pharmaceuticals & Biotechnology | 2.93% | — |
| Eternal | Retailing | 2.92% | -0.22% |
| Mahindra & Mahindra | Automobiles | 2.73% | -0.45% |
| GE Vernova T&D | Electrical Equipment | 2.61% | — |
| Prestige Estates Projects | Realty | 2.56% | -0.40% |
| Star Health Insurance | Insurance | 2.53% | +0.82% |
| JSW Infrastructure | Transport Infrastructure | 2.53% | +0.00% |
View all 43 holdings
| Jubilant FoodWorks | Leisure Services | 2.42% | -0.33% |
| Global Health | Equity | 2.36% | +0.05% |
| Coforge | IT - Software | 2.36% | -0.44% |
| Mamaearth | Personal Products | 2.33% | +0.14% |
| Devyani International | Leisure Services | 2.29% | +0.25% |
| Balkrishna Industries | Auto Components | 2.17% | -0.28% |
| Hindustan Aeronautics | Aerospace & Defense | 2.14% | -0.16% |
| ACME Solar Holdings | Power | 2.12% | +0.09% |
| IPCA Laboratories | Pharmaceuticals & Biotechnology | 2.08% | -0.15% |
| TBO Tek | Leisure Services | 2.06% | +0.92% |
| Radico Khaitan | Beverages | 2.03% | -0.15% |
| Triparty Repo | Reverse Repo / TREPS | 2.03% | — |
| Deepak Nitrite | Chemicals & Petrochemicals | 1.94% | -0.38% |
| Nykaa | Retailing | 1.89% | -0.27% |
| Samvardhana Motherson International | Auto Components | 1.88% | -0.18% |
| Dr. Lal Path Labs | Equity | 1.72% | — |
| Navin Fluorine International | Chemicals & Petrochemicals | 1.71% | -0.18% |
| Trent | Retailing | 1.63% | -0.24% |
| JSW Cement | Cement & Cement Products | 1.62% | -0.26% |
| Allied Blenders & Distillers | Beverages | 1.58% | +0.16% |
| L&T Finance | Finance | 1.58% | -0.42% |
| PB FinTech | Financial Technology (Fintech) | 1.56% | -1.32% |
| Container Corporation of India | Transport Services | 1.44% | -0.28% |
| Poonawalla Fincorp | Finance | 1.16% | -0.11% |
| Eicher Motors | Automobiles | 1.15% | -0.19% |
| NTPC Green Energy | Power | 1.12% | +0.00% |
| Cash Margin - CCIL | Net Current Assets | 0.01% | — |
| Net Current Assets | Net Current Assets | -0.61% | — |
Sector Allocation · Sep 2026
View all 23 sectors
Risk Metrics
Standard Deviation
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 15.62 | 16.32 | Low Volatility |
What is this?
Annualized population standard deviation of daily denomination-adjusted NAV returns, multiplied by sqrt(252). Values require a full timeframe of NAV history.
Sharpe Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | -0.08 | -0.32 | Above Average |
| 3Y | 0.28 | -0.45 | Above Average |
What is this?
Annualized Sharpe ratio calculated from month-end NAV returns using the latest available FBIL Overnight MIBOR rate as the risk-free rate. For schemes with less than three years of history, the 3Y value uses since-inception data. Applied risk-free rate: 5.73% (published 2026-10-28).
Sortino Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 0.63 | 0.19 | Above Average |
What is this?
Annualized from daily NAV returns using a 0.00% minimum acceptable return; downside deviation includes only returns below this target.
Compare With Peers
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
Nippon India Taiwan Equity Fund
Regular Plan · IDCW option
|
+59.64% | +47.37% | — | +23.17% |
|
HDFC Pharma and Healthcare Fund
Direct Plan · IDCW Option
|
+25.51% | +31.04% | — | +30.18% |
|
Kotak Healthcare Fund
Regular Plan · IDCW Option
|
+23.57% | — | — | +20.10% |
|
SBI Automotive Opportunities Fund
Direct Plan · IDCW
|
+22.37% | — | — | +11.34% |
|
Mirae Asset Healthcare Fund
Direct Plan · Growth
|
+21.28% | +24.36% | +16.89% | +22.00% |
|
ICICI Prudential US Bluechip Equity Fund
Regular Plan · IDCW
|
+20.32% | +18.33% | +12.09% | +15.77% |
|
PGIM India Healthcare Fund
Direct Plan · Direct IDCW
|
+20.03% | — | — | +11.89% |
|
Nippon India Japan Equity Fund
Regular Plan · Bonus Option
|
+18.89% | +19.86% | +8.28% | +8.45% |
|
HDFC Defence Fund
Regular Plan · IDCW Option
|
+18.80% | +34.56% | — | +36.67% |
|
HSBC India Export Opportunities Fund
Direct Plan · Growth
|
+18.74% | — | — | +9.24% |
More From Nippon Life India Asset Management Limited
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
Nippon India Taiwan Equity Fund
Direct Plan · Growth Option
|
+61.78% | +49.40% | — | +24.96% |
|
Nippon India Silver ETF
Direct Plan
|
+26.05% | +36.23% | — | +25.08% |
|
Nippon India Silver ETF FOF
Direct Plan · IDCW Option
|
+24.99% | +35.38% | — | +24.09% |
|
Nippon India Nifty Pharma ETF
Direct Plan
|
+22.83% | +22.93% | +15.06% | +13.35% |
|
Nippon India Japan Equity Fund
Direct Plan · IDCW Option
|
+20.27% | +21.27% | +9.63% | +9.56% |
|
Nippon India ETF Gold BeES
Direct Plan
|
+16.58% | +30.82% | +23.10% | +15.30% |
|
Nippon India Gold Savings Fund
Direct Plan · Growth Option
|
+16.51% | +30.76% | +22.97% | +10.34% |
|
Nippon India US Equity Opportunities Fund
Direct Plan · IDCW Option
|
+11.90% | +18.73% | +10.93% | +14.93% |
|
Nippon India Pharma Fund
Direct Plan · Growth Option
|
+10.54% | +18.85% | +14.53% | +17.34% |
|
Nippon India Fixed Maturity Plan - XLV - Series 5
Direct Plan · Growth Option
|
+7.36% | +8.43% | — | +8.54% |
About This Scheme
Investment Objective
The investment objective of the scheme is to achieve long-term capital appreciation for its investors. This objective will be pursued by strategically investing in a diversified portfolio of equity and equity-related instruments. The selection of these instruments will be based on a quantitative model meticulously designed to identify potential investment opportunities that exhibit the potential for significant capital appreciation over the specified investment horizon. There is no assurance that the investment objective of the Scheme will be achieved.
Stated Asset Allocation
Equity and Equity related Instruments of Momentum Theme - 80%-100%, Debt & Money Market instruments – 0%-20%, Units issued by REITs and InvITs - 0%-10%
Exit Load
1% if redeemed or switched out on or before completion of 1 year from the date of allotment of units.Nil, thereafter.
Fund Managers
Shirish Guthe
Primary
Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. Data is sourced from AMFI and fund houses via FinAPI and may lag official figures.
GMP IPO Watch